The University of Kansas Cancer Center
Locations
Transplant Summary
Overview
The University of Kansas Cancer Center is a nationally recognized leader in the fight to treat and cure cancer. In 2022, our center achieved National Cancer Institute (NCI) Comprehensive Cancer Center designation, one of only 56 in the US. Blood and marrow transplant specialists at The University of Kansas Cancer Center are nationally recognized hematologists/oncologists. Through research and clinical trials, we constantly develop new therapies to save more lives.
Our FACT accredited program has been performing allogeneic transplant since 1977 and has been an NMDP transplant center since 1994. Over the past decade, we have developed one of the largest bone marrow transplant and cellular therapeutics programs in the nation. We perform over 300 transplants annually, and we have performed over 5,000 transplants since 1977. We have performed over 300 CAR-T therapies since 2015.This center has been performing allogeneic transplants since 1977 and has been an NMDP transplant center since September 1994.
Attending physicians
Adult - Haitham Abdelhakim, Sunil Abhyankar, Nasheen Ahmed, Rajat Bansal, Lutfi Forat, Joseph P. McGuirk, Muhammed Mushtaq, Leyla Shune, Anurug Singh, Anthony SungTransplants performed
Marrow/PBSC, single cord, and double cordCord blood transplants
Adult onlyOther programs and services
Housing for caregiver/recipient at American Cancer Society (ACS) Hope Lodge
Fisher House Kansas City (for veterans)Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 351 patients.The actual 1-year survival of these patients is 74.4%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 70.6% and 79.3%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
622
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow27PBSC120Cord blood0Total147Unrelated donorMarrow19PBSC100Cord blood0Total119Total allogeneicMarrow46PBSC220Cord blood0Total266AutologousMarrowBoth marrow & PBSC 356PBSC—Cord blood—Total356Total combinedMarrowBoth marrow & PBSC 622PBSC—Cord blood0Total622All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-18019-443145-646765+49Total147Unrelated 0-18019-442145-644565+53Total119Autologous 0-18019-443645-6417065+150Total356Total 0-18019-448845-6428265+252Total622Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
If you have questions about costs and financial services at this center, please call the transplant center’s direct phone number.NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
The University of Kansas Cancer Center
2650 Shawnee Mission ParkwaySuite 3305, Mail Stop 5019 Westwood, KS 66205 Phone:913-588-1227 Physician Referrals:844-323-1227 (toll-free) For more information about this program: http://kucancercenter.org/bmt (Opens in a new tab)Overview
The BMT and cellular therapy survivorship program fulfills a need in our patient community: We specialize in caring for the needs of posttransplant and cellular therapy patients transitioning to life after treatment. Survivors have a unique set of healthcare needs due to late and long-term effects of chemotherapy and/or radiation. Posttransplant and cellular therapy challenges affect the physical and mental health of survivors, as well as their quality of life.
Staff
Program Director:Nausheen Ahmed, MDProgram Coordinator:Cherie Morey, APRNMedical Specialties in Program
Cardiology, complementary and alternative medicine, dentistry, dermatology, endocrinology, hematology, neurology, ophthalmology/optometry, palliative care, PMR, psychiatry/psychology, pulmonology.Medical Services Offered
Chronic GVHD management, fertility counseling, reproductive health, financial counseling, nutrition/dietetics, occupational therapy, pain management, physical therapy and rehabilitation, sexual health, social services, vaccinations.Telemedicine services are available.Patient Eligibility
Adults- Allogeneic and Autologous transplant recipients
- Adults: 12 months after transplant.
- Adults (over age 20)
- Will provide care to adult patients who underwent transplant as a child
- Does accept patients who were transplanted at another hospital